Ovagen is an EDL-targeting tripeptide developed by a Russian research team. It is an organ-regulating peptide, intended only as a laboratory research raw material, and does not possess pharmaceutical qualifications; it cannot be used for the treatment of human diseases. Key parameters: CAS No. 9046-70-2, molecular weight 375.37 Da, standard research purity ≥98%, high-end experimental grade up to 99.5%, appearance: white, water-soluble, lyophilized powder, suitable for various biochemical research experiments.
Its core function is to provide dual repair for the liver and gastrointestinal tract. It can repair damaged liver cells, reduce liver damage-related indicators, alleviate oxidative liver damage caused by alcohol and drugs, and delay liver aging. Simultaneously, it can repair the gastrointestinal mucosa, stabilize the intestinal barrier, and alleviate chronic intestinal inflammation and digestive metabolic disorders. Furthermore, it can participate in the regulation of germ cell aging and is a commonly used raw material in basic antiviral pharmacology research, suitable for various research projects.
The product has significant advantages. As a small molecule tripeptide, it has both oral and injectable absorption pathways, offering flexible usage and strong adaptability. Unlike single-ingredient liver-protecting ingredients, this product offers dual regulation of the liver and gut, and can be freely combined with multiple organ peptides for the development of complex anti-aging formulas. The ingredient exhibits high safety for short-term use, with no significant toxic side effects, no dependence, and good experimental tolerability.
However, the product has significant drawbacks. All experimental data comes solely from Russian research, lacking authoritative third-party verification from Europe and the US, as well as large-scale human clinical data, limiting its scientific validation. Its efficacy relies on gene regulation, resulting in a long treatment cycle, making it difficult to observe significant changes in indicators in short-term experiments. Storage conditions are stringent: the dry powder must be stored at -20℃ in a light-proof, sealed container; after reconstitution, it can only be refrigerated at 2–8℃, and repeated freeze-thaw cycles are strictly prohibited, leading to high transportation and storage costs. Furthermore, there is currently no complete data to support the safety risks of long-term continuous use, and it is subject to regulatory restrictions, prohibiting claims of medical efficacy.
Standard packaging includes 10–50mg vials for sample testing and 1–100g bulk powder, meeting the needs of small-scale experiments and large-scale research and development. Main applications include liver and intestinal injury model experiments, digestive barrier research, reproductive aging studies, basic antiviral pharmacology experiments, and research and development of compound peptide formulations and raw material supply for export.
How to Order?
First, please inform us of your needs or application scenario.
Second, we will provide a quotation based on your needs or our suggestions.
Third, the customer confirms the sample and pays a deposit.
Fourth, we are responsible for arranging production. Discounts are available for bulk orders.
How is the quality of your products? First, our products are of excellent and stable quality. We conduct 100% testing before shipment.
Therefore, we conduct strict quality control before shipment. If any quality problems are found to be caused by us, we will replace the product free of charge or provide a refund.
How to Establish a Long-Term, Positive Partnership with Us?
1. We insist on providing high-quality products and competitive prices to ensure customer benefits;
2. We respect every customer, treat them as friends, and sincerely do business and make friends with them, no matter where they come from.
Hot Tags: high-quality peptide ovagen 20mg/vial, China high-quality peptide ovagen 20mg/vial manufacturers, suppliers, factory
